It has been vastly shown that EZH2 is increased in breast cancer and aggravates breast cancer by regulating various genes expression in canonical manners, such as FOXC1, SOX4, CDKN2A, et al. 3,5,6. This evidence concerns the gene EZH2 and breast carcinoma.